Press release
Dry Age Macular Degeneration Market to Witness an Upsurge in Growth by 2034, Examines DelveInsight
Dry Age Macular Degeneration Pipeline
Key Takeaways from the Dry AMD Market Research Report
• The total Dry Age Macular Degeneration prevalent cases in the 7MM was nearly 68,347,900 in 2023.
• Among the 7MM, the US accounted for the highest prevalent cases of dry AMD in 2023, with around 20,970,000 cases; these cases are expected to increase during the forecast period.
• The leading Dry Age Macular Degeneration Companies working in the market include Alkeus Pharmaceuticals, Belite Bio, Aviceda Therapeutics, Johnson & Johnson Innovative Medicine, Allegro Ophthalmics, Lineage Cell Therapeutics (CellCure Neurosciences), Roche, Cognition Therapeutics, Stealth BioTherapeutics, Evergreen Therapeutics, Annexon Biosciences, NGM Biopharmaceuticals, AstraZeneca, Alexion Pharmaceuticals, Ionis Pharmaceuticals, Novartis, Regenerative Patch Technologies, and others.
• Promising Dry Age Macular Degeneration Therapies in the various stages of development include Gildeuretinol (ALK-001), Tinlarebant (LBS-008), AVD-104, JNJ-1887, Luminate (risuteganib), OpRegen, CT1812, Elamipretide, EG-301, ANX007, NGM621, Danicopan (ALXN2040), IONIS-FB-LRx, Iptacopan (LNP023), CPCB-RPE1, and others.
• April 2024:- LumiThera Inc- This study is an open-label, prospective, multi-center extension study on the continued use of photobiomodulation (PBM) in subjects with dry age-related macular degeneration (AMD) that participated in the CSP005 LIGHTSITE III study.
• January 2024:- Pixium Vision SA- In this study, the principle functionality of the device will be tested in humans for the first time. The study will evaluate the extent to which patients with atrophic dry age related macular degeneration (AMD) have evoked light perception using the implant.
• January 2024:- Smilebioteck Zhuhai Limited- This is a phase 2, double-masked, randomized, placebo-controlled, dose-response study. The primary objective of the study is to evaluate the efficacy of QA102 oral capsules on the development of soft drusen, visual acuity (VA), and geographic atrophy (GA) or choroidal neovascularization (CNV) or the progression of GA in subjects with intermediate to advanced dry AMD.
Discover which therapies are expected to grab the Dry Age Macular Degeneration Market Share @ Dry Age Macular Degeneration Market Outlook- https://www.delveinsight.com/sample-request/dry-age-macular-degeneration-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Dry Age Macular Degeneration Overview
Dry Age-Related Macular Degeneration (AMD) is a common eye condition that affects the macula, a small area in the center of the retina responsible for sharp, central vision. In this condition, the macula deteriorates over time, leading to gradual loss of central vision. "Dry" refers to the absence of abnormal blood vessel growth, which is characteristic of the wet form of AMD. Dry AMD typically progresses slowly and may result in blurred vision, difficulty seeing in low light, and eventual loss of central vision, though peripheral vision usually remains intact.
Dry Age Macular Degeneration Epidemiology Insights
The epidemiology section of Dry Age Macular Degeneration offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.
Download the report to understand which factors are driving Dry Age Macular Degeneration Epidemiology trends @ Dry Age Macular Degeneration Epidemiological Insights- https://www.delveinsight.com/sample-request/dry-age-macular-degeneration-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Dry Age Macular Degeneration Drugs Market
The Dry Age Macular Degeneration Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Dry Age Macular Degeneration signaling in Dry Age Macular Degeneration are likely to uncover new therapeutic targets and further expand treatment options for patients.
Dry Age Macular Degeneration Treatment Market Landscape
The Dry Age Macular Degeneration treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Dry Age Macular Degeneration has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.
To learn more about Dry Age Macular Degeneration treatment guidelines, visit @ Dry Age Macular Degeneration Treatment Market Landscape- https://www.delveinsight.com/sample-request/dry-age-macular-degeneration-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Dry Age Macular Degeneration Market Outlook
The report's outlook on the Dry Age Macular Degeneration market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Dry Age Macular Degeneration therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Dry Age Macular Degeneration drug and late-stage pipeline therapy. It assesses their impact based on various factors such as annual therapy costs, inclusion/exclusion criteria, mechanism of action, compliance rates, market demand, patient population growth, covered patient segments, anticipated launch year, competition with other therapies, brand value, and input from key opinion leaders. The analyzed Dry Age Macular Degeneration market data are presented concisely through relevant tables and graphs to offer a clear overview of the market dynamics.
Dry Age Macular Degeneration Drugs Uptake
The drug chapter of the Dry Age Macular Degeneration report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Dry Age Macular Degeneration.
Major Dry Age Macular Degeneration Companies
Several Dry Age Macular Degeneration Companies working in the market include Alkeus Pharmaceuticals, Belite Bio, Aviceda Therapeutics, Johnson & Johnson Innovative Medicine, Allegro Ophthalmics, Lineage Cell Therapeutics (CellCure Neurosciences), Roche, Cognition Therapeutics, Stealth BioTherapeutics, Evergreen Therapeutics, Annexon Biosciences, NGM Biopharmaceuticals, AstraZeneca, Alexion Pharmaceuticals, Ionis Pharmaceuticals, Novartis, Regenerative Patch Technologies, and others.
Learn more about the FDA-approved drugs for Dry Age Macular Degeneration @ Drugs for Dry Age Macular Degeneration Treatment- https://www.delveinsight.com/sample-request/dry-age-macular-degeneration-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Dry Age Macular Degeneration Market Report
• Coverage- 7MM
• Dry Age Macular Degeneration Companies- Alkeus Pharmaceuticals, Belite Bio, Aviceda Therapeutics, Johnson & Johnson Innovative Medicine, Allegro Ophthalmics, Lineage Cell Therapeutics (CellCure Neurosciences), Roche, Cognition Therapeutics, Stealth BioTherapeutics, Evergreen Therapeutics, Annexon Biosciences, NGM Biopharmaceuticals, AstraZeneca, Alexion Pharmaceuticals, Ionis Pharmaceuticals, Novartis, Regenerative Patch Technologies, and others.
• Dry Age Macular Degeneration Therapies- Gildeuretinol (ALK-001), Tinlarebant (LBS-008), AVD-104, JNJ-1887, Luminate (risuteganib), OpRegen, CT1812, Elamipretide, EG-301, ANX007, NGM621, Danicopan (ALXN2040), IONIS-FB-LRx, Iptacopan (LNP023), CPCB-RPE1, and others.
• Dry Age Macular Degeneration Market Dynamics: Dry Age Macular Degeneration Market Drivers and Barriers
• Dry Age Macular Degeneration Market Access and Reimbursement, Unmet Needs and Future Perspectives
Discover more about Dry Age Macular Degeneration Drugs in development @ Dry Age Macular Degeneration Clinical Trials Assessment- https://www.delveinsight.com/sample-request/dry-age-macular-degeneration-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Key Insights
2. Report Introduction
3. Executive Summary of Dry AMD
4. Key Events
5. Epidemiology and Market Forecast Methodology
6. Dry AMD Market Overview at a Glance
7. Disease Background and Overview
8. Epidemiology and Patient Population
9. Patient Journey
9.1. Description
10. Marketed Drugs
11. Emerging Drugs
12. Dry AMD: Market Analysis
13. Unmet Needs
14. SWOT Analysis
15. KOL Views
16. Market Access and Reimbursement
17. Appendix
18. DelveInsight Capabilities
19. Disclaimer
20. About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website:- https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dry Age Macular Degeneration Market to Witness an Upsurge in Growth by 2034, Examines DelveInsight here
News-ID: 3482539 • Views: …
More Releases from DelveInsight Business Research LLP
Hair Disease Market Outlook Report 2032 | Procter & Gamble Company, Unilever PLC …
DelveInsight's "Hair Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Hair Disease, historical and forecasted epidemiology, as well as the Hair Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Hair Disease market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Hair Disease market size…
Hepatic Impairment Market Outlook Report 2032 | Abbott Laboratories, Gilead Scie …
Hepatic Impairment Market Outlook Report 2032 | Abbott Laboratories, Gilead Sciences, Novartis AG, Sanofi, Astellas Pharma Inc
DelveInsight's "Hepatic Impairment Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Hepatic Impairment, historical and forecasted epidemiology as well as the Hepatic Impairment market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Hepatic Impairment market report provides current treatment practices, emerging drugs,…
Hyperpigmentation Market Outlook Report 2032 |Episciences, Vivier Pharma, La Roc …
DelveInsight's "Hyperpigmentation Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Hyperpigmentation, historical and forecasted epidemiology as well as the Hyperpigmentation market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Hyperpigmentation market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Hyperpigmentation market size from 2019 to 2032, segmented…
Hypoventilation Market Report Outlook 2032 | Accord Healthcare Limited, Avet Pha …
DelveInsight's "Hypoventilation Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Hypoventilation, historical and forecasted epidemiology as well as the Hypoventilation market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Hypoventilation market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Hypoventilation market size from 2019 to 2032, segmented by…
More Releases for Dry
Dry Ice Market In-Depth Analysis | Key Participants Dry Ice Corp., Dry Ice UK Lt …
Demand for dry ice is expected to magnify with the development of dry ice machines industry across the globe. Manufacturers in large multinational organizations and private firms have been contributing prominently in the revenue growth of dry ice market. Dry ice being a cost-effective product is expected to bolster its demand across various applications in the near future. Rising number of fire accidents leads to increasing demand for dry ice,…
Dry Screw Vacuum Pumps
Swam Dry vacuum pumps are the latest development in the vacuum pump industry. They offer a number of advantages over traditional vacuum pump designs. Best process gas blowers. There is “NO OIL / NO WATER” contact with the process vapours, which is why they are considered extremely environmentally friendly.
Visit us for more info - http://swamatics.com/ProductDetails.aspx?prod=Process%20Gas%20Blowers/Gas%20Boosters
The definition of a dry vacuum pump is a pump that does not use any…
Dry Bulk Shipping Market to Witness Astonishing Growth during Forecast 2025 | Di …
This report examines Dry Bulk Shipping markets in various aspects of the industry, including market size, market conditions, market trends, forecasts, and more, with brief information on competitors and specific growth by key market drivers. We also provide opportunities. In the report, find a complete Dry Bulk Shipping market analysis broken down by company, region, type, and application.
Some of the key player’s analysis in the Dry Bulk Shipping market:
Diana…
Prepared Dry Foods Market | Key Players : Oregon Freeze Dry, Inc., European Free …
Prepared dry foods are processed food products treated with heat to remove their water content, which makes it inhospitable to most microbes and thus increases the shelf life of the food product. Microbes need water as well as organic content to grow, making the elimination of water a simple and effective way of ensuring the food doesn’t spoil.
For more information on Prepared Dry Foods Market, get free sample report @…
Pet Dry Food 2025 by Key Product - Canned, Pate, Dry Food and International Outl …
The global Pet Dry Food market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.
The major manufacturers covered in this report
Ainsworth Pet Nutrition
Big Heart Pet Brands
National Flour Mills
Natural Balance Pet Foods
Rush Direct
Simmons Pet Food
Almo Nature
Aller Petfood
C.J. Foods
Deuerer
Canidae Corp.
Gimborn
Cargill
Crosswind Industries Inc.
Evanger's
Hubbard Feeds
Life's Abundance
Request a Sample at http://www.reportsweb.com/inquiry&RW00012089930/sample
The study objectives of this report are:
To analyze and study…
Dry Concrete Market- What are the Effects of Using Dry Concrete with Detailed Sp …
Market Overview
The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Dry Concrete by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Objective of the Study:
• To outline, classify and estimate the Global Dry Concrete market on the basis…
